JAZZ logo

Jazz Pharmaceuticals (JAZZ) Total expenses

Annual total expenses:

$3.34B+$105.70M(+3.27%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual total expenses is $3.34 billion, with the most recent change of +$105.70 million (+3.27%) on December 31, 2024.
  • During the last 3 years, JAZZ annual total expenses has risen by +$418.36 million (+14.31%).
  • JAZZ annual total expenses is now at all-time high.

Performance

JAZZ Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Quarterly total expenses:

$953.73M+$56.33M(+6.28%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly total expenses is $953.73 million, with the most recent change of +$56.33 million (+6.28%) on March 1, 2025.
  • Over the past year, JAZZ quarterly total expenses has increased by +$127.96 million (+15.50%).
  • JAZZ quarterly total expenses is now at all-time high.

Performance

JAZZ Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

JAZZ Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+3.3%+15.5%
3 y3 years+14.3%+31.3%
5 y5 years+120.0%+147.1%

JAZZ Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+14.3%at high+31.3%
5 y5-yearat high+120.0%at high+164.0%
alltimeall timeat high+4153.1%at high+3448.9%

JAZZ Total expenses History

DateAnnualQuarterly
Mar 2025
-
$953.73M(+6.3%)
Dec 2024
$3.34B(+3.3%)
$897.40M(+12.9%)
Sep 2024
-
$794.76M(-3.6%)
Jun 2024
-
$824.38M(-0.2%)
Mar 2024
-
$825.78M(-5.2%)
Dec 2023
$3.24B(+2.8%)
$871.44M(+9.0%)
Sep 2023
-
$799.75M(+0.0%)
Jun 2023
-
$799.68M(+4.4%)
Mar 2023
-
$765.76M(-11.0%)
Dec 2022
$3.15B(+7.6%)
$860.51M(+10.0%)
Sep 2022
-
$782.24M(+0.5%)
Jun 2022
-
$778.18M(+7.2%)
Mar 2022
-
$726.17M(-14.3%)
Dec 2021
$2.92B(+83.0%)
$847.35M(+4.6%)
Sep 2021
-
$809.75M(-1.4%)
Jun 2021
-
$821.40M(+84.4%)
Mar 2021
-
$445.46M(-2.3%)
Dec 2020
$1.60B(+5.2%)
$456.10M(+15.6%)
Sep 2020
-
$394.68M(+9.2%)
Jun 2020
-
$361.31M(-6.4%)
Mar 2020
-
$386.01M(-25.8%)
Dec 2019
$1.52B(+23.2%)
$520.50M(+47.5%)
Sep 2019
-
$352.82M(+7.7%)
Jun 2019
-
$327.65M(+2.9%)
Mar 2019
-
$318.44M(+9.3%)
Dec 2018
$1.23B(+22.7%)
$291.40M(+3.9%)
Sep 2018
-
$280.60M(-7.8%)
Jun 2018
-
$304.38M(-14.7%)
Mar 2018
-
$356.81M(+24.2%)
Dec 2017
$1.00B(+15.2%)
$287.19M(+14.7%)
Sep 2017
-
$250.40M(+10.1%)
Jun 2017
-
$227.34M(-5.2%)
Mar 2017
-
$239.91M(+3.8%)
Dec 2016
$872.57M(+11.1%)
$231.12M(+3.7%)
Sep 2016
-
$222.93M(+4.9%)
Jun 2016
-
$212.43M(+3.1%)
Mar 2016
-
$206.10M(+1.7%)
DateAnnualQuarterly
Dec 2015
$785.06M(+6.8%)
$202.73M(-3.2%)
Sep 2015
-
$209.34M(+16.0%)
Jun 2015
-
$180.45M(-6.3%)
Mar 2015
-
$192.54M(+0.8%)
Dec 2014
$735.30M(+39.5%)
$191.04M(+10.1%)
Sep 2014
-
$173.55M(-5.7%)
Jun 2014
-
$184.13M(-1.3%)
Mar 2014
-
$186.58M(+32.1%)
Dec 2013
$527.12M(+35.8%)
$141.28M(+8.2%)
Sep 2013
-
$130.61M(-0.4%)
Jun 2013
-
$131.19M(+5.8%)
Mar 2013
-
$124.05M(+6.6%)
Dec 2012
$388.13M(+168.7%)
$116.32M(-3.2%)
Sep 2012
-
$120.22M(+41.8%)
Jun 2012
-
$84.80M(+27.0%)
Mar 2012
-
$66.79M(+45.6%)
Dec 2011
$144.45M(+24.5%)
$45.87M(+15.9%)
Sep 2011
-
$39.59M(+28.9%)
Jun 2011
-
$30.71M(+8.6%)
Mar 2011
-
$28.28M(+1.6%)
Dec 2010
$115.99M(+3.1%)
$27.83M(-8.2%)
Sep 2010
-
$30.31M(+1.4%)
Jun 2010
-
$29.90M(+7.0%)
Mar 2010
-
$27.94M(+4.0%)
Dec 2009
$112.52M(-45.9%)
$26.87M(-0.8%)
Sep 2009
-
$27.10M(-7.3%)
Jun 2009
-
$29.25M(-0.2%)
Mar 2009
-
$29.30M(-29.5%)
Dec 2008
$208.12M(+2.0%)
$41.55M(-8.7%)
Sep 2008
-
$45.49M(-27.4%)
Jun 2008
-
$62.63M(+7.2%)
Mar 2008
-
$58.44M(-21.3%)
Dec 2007
$204.08M(+66.0%)
$74.22M(+89.0%)
Sep 2007
-
$39.27M(-31.1%)
Jun 2007
-
$57.02M(+69.8%)
Mar 2007
-
$33.57M
Dec 2006
$122.91M(+56.4%)
-
Dec 2005
$78.59M
-

FAQ

  • What is Jazz Pharmaceuticals annual total expenses?
  • What is the all time high annual total expenses for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual total expenses year-on-year change?
  • What is Jazz Pharmaceuticals quarterly total expenses?
  • What is the all time high quarterly total expenses for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly total expenses year-on-year change?

What is Jazz Pharmaceuticals annual total expenses?

The current annual total expenses of JAZZ is $3.34B

What is the all time high annual total expenses for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual total expenses is $3.34B

What is Jazz Pharmaceuticals annual total expenses year-on-year change?

Over the past year, JAZZ annual total expenses has changed by +$105.70M (+3.27%)

What is Jazz Pharmaceuticals quarterly total expenses?

The current quarterly total expenses of JAZZ is $953.73M

What is the all time high quarterly total expenses for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly total expenses is $953.73M

What is Jazz Pharmaceuticals quarterly total expenses year-on-year change?

Over the past year, JAZZ quarterly total expenses has changed by +$127.96M (+15.50%)
On this page